title: Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter.
abstract: We have identified a homozygous G>A substitution in the donor splice site of intron 6 (IVS6 + 1G>A) of the cytidine monophosphate (CMP)-sialic acid transporter gene of Lec2 cells as the mutation responsible for their asialo phenotype. These cells were used in complementation studies to test the activity of the 2 CMP-sialic acid transporter cDNA alleles of a patient devoid of sialyl-Le(x) expression on polymorphonuclear cells. No complementation was obtained with either of the 2 patient alleles, whereas full restoration of the sialylated phenotype was obtained in the Lec2 cells transfected with the corresponding human wild-type transcript. The inactivation of one patient allele by a double microdeletion inducing a premature stop codon at position 327 and a splice mutation of the other allele inducing a 130-base pair (bp) deletion and a premature stop codon at position 684 are proposed to be the causal defects of this disease. A 4-base insertion in intron 6 was found in the mother and is proposed to be responsible for the splice mutation. We conclude that this defect is a new type of congenital disorder of glycosylation (CDG) of type IIf affecting the transport of CMP-sialic acid into the Golgi apparatus.
authors.affiliation: Inistitut National de la Santé et de la Recherche Médicale (INSERM U504), Groupement de Recherche (GDR), Centre National de la Recherche Scientifque (CNRS) 2590, University of Paris Sud XI, Villejuif 94807, France. martinez@vjf.inserm.fr
authors.forename: Ivan
authors.initials: I
authors.lastname: Martinez-Duncker
authors.forename: Thierry
authors.initials: T
authors.lastname: Dupré
authors.forename: Véronique
authors.initials: V
authors.lastname: Piller
authors.forename: Friedrich
authors.initials: F
authors.lastname: Piller
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Candelier
authors.forename: Catherine
authors.initials: C
authors.lastname: Trichet
authors.forename: Gil
authors.initials: G
authors.lastname: Tchernia
authors.forename: Rafael
authors.initials: R
authors.lastname: Oriol
authors.forename: Rosella
authors.initials: R
authors.lastname: Mollicone
mesh_terms: D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D016466:CHO Cells; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism; D003001:Cloning, Molecular; D006224:Cricetinae; D003568:Cytidine Monophosphate / Q000378:metabolism*; D018076:DNA, Complementary; D017353:Gene Deletion; D006031:Glycosylation; D006056:Golgi Apparatus / Q000378:metabolism*; D007438:Introns / Q000235:genetics; D008969:Molecular Sequence Data; D019158:N-Acetylneuraminic Acid / Q000378:metabolism*; D033704:Nucleotide Transport Proteins / Q000235:genetics* / Q000378:metabolism*; D010290:Parents; D012333:RNA, Messenger / Q000032:analysis
chemical_list: D002352:Carrier Proteins; D018076:DNA, Complementary; D033704:Nucleotide Transport Proteins; D012333:RNA, Messenger; C491081:SLC35A1 protein, human; D003568:Cytidine Monophosphate; D019158:N-Acetylneuraminic Acid